Nanoplastics interact with a particular protein that is naturally found in the brain, creating changes linked to Parkinson’s disease and some types of dementia.
4P-Pharma raises €15M; Oncotelic Therapeutics sells rights to cancer assets
Plus, news about Adaptilens: 4P-Pharma secures €15M in second closing: The fundraise, which was backed by private investors, will be used to support the French biotech as